|
91
|
Product specific BE guideline |
Esomeprazole magnesium delayed release tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
92
|
Quality |
病毒載體之基因治療製劑化學製造管制研發策略指導原則
|
2025-09-24 |
|
93
|
Pharm/tox |
藥品光安全性評估指導原則
|
2025-09-24 |
|
94
|
Product specific BE guideline |
Sildenafil Citrate Tablets_學名藥生體相等性試驗指導原則
|
2025-09-24 |
|
95
|
Product specific BE guideline |
Dabigatran Etexilate Mesylate Hard Capsules_學名藥生體相等性試驗指導原則
|
2025-09-24 |
|
96
|
Product specific BE guideline |
Agomelatine Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
97
|
Product specific BE guideline |
Entecavir Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
98
|
Product specific BE guideline |
Levofloxacin Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
99
|
Product specific BE guideline |
Methylphenidate ER Tablet_生體相等性試驗指導原則
|
2025-09-24 |
|
100
|
Product specific BE guideline |
Oseltamivir Phosphate capsule_生體相等性試驗指導原則
|
2025-09-24 |
